Literature DB >> 12737294

Cholesteatoma epithelium is characterized by increased expression of Ki-67, p53 and p21, with minimal apoptosis.

Margriet A Huisman1, Emile De Heer, Jan J Grote.   

Abstract

OBJECTIVE: To investigate differences in cell proliferation, cell cycle arrest and apoptosis between cholesteatoma and control skin.
MATERIAL AND METHODS: Immunohistochemical sections of 15 cholesteatoma and 15 paired control retro-auricular skin samples were examined for Ki-67, p53, p21 and active caspase 3, using image analysis, as well as for DNA fragmentation.
RESULTS: The retro-auricular skin samples contained 5.7% +/- 3.6%, Ki-67-positive cells and showed a normal expression pattern. In the cholesteatoma epithelium 11.7% +/- 9.5% of the cells were Ki-67-positive and these cells were dominantly expressed in the basal and parabasal cell layers. Retro-auricular skin contained 5.8% +/- 5.4% p53-positive cells and 1.0% +/- 0.9%, p21-positive cells. In the cholesteatoma epithelium 17.8% +/- 12.3% of the cells were p53-positive and 14.3% +/- 11.6% were p21-positive The expression of Ki-67, p53 and p21 differed significantly between the two groups (p < 0.05). In the cholesteatoma epithelium a positive correlation was found between p53 and p21 expression (p = 0.016). Active caspase 3 positivity and DNA fragmentation were rarely seen in the cholesteatoma epithelium.
CONCLUSION: Our results indicate that increased cell proliferation in cholesteatoma epithelium is accompanied by an increase in p53 and p21 protein levels, whilst apoptosis is minimal.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12737294     DOI: 10.1080/00016480310001376

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  8 in total

1.  Evaluation of the Ki-67 Proliferation Index and Urocortin Expression in Women with Ovarian Endometriomas.

Authors:  Serenat Eris Yalcin; Irfan Ocal; Yakup Yalcin; Halime Sen Selim; Melike Demir Caltekin; Huseyin Aydogmus; Sefa Kelekci
Journal:  Eurasian J Med       Date:  2017-06

2.  Investigation of the effect of metoclopramide on proliferation signal molecules in breast tissue.

Authors:  Nurcan Umur; Selda İldan Çalım; Gülce Naz Yazıcı; Seren Gulsen Gurgen
Journal:  Int J Exp Pathol       Date:  2022-03-03       Impact factor: 2.793

3.  A Case Report of a Giant Cholesteatoma.

Authors:  Neelam Sood; Binit Kumar Khandelia; Gitanjali Bugnait
Journal:  J Clin Diagn Res       Date:  2017-03-01

4.  Could cellular proliferation be a predictive index for the relapse of nasal polyposis and down-regulated by nasal steroid treatment?

Authors:  Ilter Tezer; Ozlem Celebi Erdivanli; Arif Sanli; Sedat Aydin
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-02-02

5.  Myeloperoxydase activity in the pathogenesis of cholesteatoma.

Authors:  Ozlem Celebi; Mustafa Paksoy; Sedat Aydin; Arif Sanlı; Omer Taşdemir; Aylin Ege Gül
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2010-06-04

6.  Comparative analysis of the epithelium stroma interaction of acquired middle ear cholesteatoma in children and adults.

Authors:  Hans-J Welkoborsky; Roland S Jacob; Mike L Hinni
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-06-01       Impact factor: 2.503

7.  Evaluation of bcl-2, bax and c-erbB-2 Levels in Chronic Otitis Patients with or without Cholesteatoma.

Authors:  Özgür Işık; Turgut Karlıdağ; Bengü Çobanoğlu Şimşek; Erol Keleş; İrfan Kaygusuz; Şinasi Yalçın; İsrafil Orhan; Emrah Sapmaz
Journal:  Turk Arch Otorhinolaryngol       Date:  2015-06-01

8.  Large-scale proteomics differentiates cholesteatoma from surrounding tissues and identifies novel proteins related to the pathogenesis.

Authors:  Anders Britze; Rune Isak Dupont Birkler; Niels Gregersen; Therese Ovesen; Johan Palmfeldt
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.